Update on Cardiac Resynchronisation Therapy for Heart Failure

Journal
Article on Update on Cardiac Resynchronisation Therapy for Heart Failure

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Overview

Cardiac resynchronisation therapy (CRT) is well accepted therapy for the treatment of symptomatic systolic heart failure in defined patient subgroups. Large clinical trials over the past 20 years have shown that patients with a left ventricular (LV) systolic dysfunction and interventricular conduction delay benefit from this therapy. Recent advances in this field include the expansion indications for CRT to patients with mild heart failure and to those with a mildly depressed ejection fraction that require frequent right ventricular pacing. In addition, although CRT guidelines have included indications in atrial fibrillation, it is now clear that this is most effective when pacing is utilised nearly 100 % of the time, often requiring atrioventricular (AV) junction ablation. Strategies for optimising LV lead placement based on identifying late mechanical contraction or electrical delay are promising for maximising CRT response. Finally, the role of routine AV delay optimisation is no longer recommended based on the results of multicentre trials.

Featuring

David D Daly Jr : Organization: Medical University of South Carolina, Charleston, South Carolina, US

Michael R Gold: Organization: Medical University of South Carolina, Charleston, South Carolina, US


Loading Simple Education